US Patent 11642398 Factor IX polypeptide formulations

Patent 11642398 was granted and assigned to Bioverativ on May, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116423980

Patent Inventor Names

Mark Brader0

Date of Patent

May 9, 2023

Patent Application Number

167736340

Date Filed

January 27, 2020

Patent Citations

‌

US Patent 10588949 Factor IX polypeptide formulations

‌

US Patent 10772942 Lyophilized factor IX formulations

Patent Primary Examiner

‌

Michael Szperka

The present invention provides formulations comprising a Factor IX-FcRn Binding Partner (FIXFBP) polypeptide, and methods of administering FIXFBP.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11642398 Factor IX polypeptide formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API